Cases & Deals

  • ArunA Biomedical issues $5.3 million of Common Stock in Reg D offering

Share

ArunA Biomedical issues $5.3 million of Common Stock in Reg D offering

July 2018

Client(s) ArunA Biomedical, Inc.

Jones Day advised ArunA Biomedical, Inc., a manufacturer of technologies in human stem cell research for use in drug discovery and development, in connection with its issuance of $5.3 million of Common Stock in a Regulation D offering.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.